GLYCOMIRA
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.
GLYCOMIRA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.glycomira.com
Total Employee:
1+
Status:
Active
Contact:
1-801-649-3999
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Google Apps For Business Google Maps GoDaddy DNS WordPress 6.0
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Current Employees Featured
Official Site Inspections
http://www.glycomira.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "GlycoMira"
About Us | GlycoMira.com
GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. GlycoMiraโs dedicated โฆSee details»
GlycoMira - Crunchbase Company Profile & Funding
Organization. GlycoMira . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. GlycoMira develops โฆSee details»
Investors | GlycoMira.com
1 As of 2024, the criteria for an individual to be considered an accredited investor include: Income Requirement: An individual must have an annual income exceeding $200,000 (or $300,000 โฆSee details»
GlycoMira Company Profile - Office Locations, Competitors ... - Craft
GlycoMira is a biotechnology company developing drug candidates against inflammatory diseases. It offers synthetic glycosaminoglycan-based therapeutics that modulate innate โฆSee details»
GLYCOMIRA THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GLYCOMIRA THERAPEUTICS, INC. of Salt Lake City, UT. Get the latest business insights from Dun & โฆSee details»
GlycoMira - Products, Competitors, Financials, Employees, โฆ
GlycoMira Therapeutics Secures Groundbreaking Patent for Novel Cancer Treatment. Nov 4, 2024. Salt Lake City, UT, November 04, 2024 โ GlycoMira Therapeutics announced that the โฆSee details»
GlycoMira - The Org
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases. Industries. Biotechnology, Health Care + 2See details»
GlycoMira - Contacts, Employees, Board Members, Advisors
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.See details»
GLYCOMIRA, LLC Company Profile | Dover, DE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GLYCOMIRA, LLC of Dover, DE. Get the latest business insights from Dun & Bradstreet.See details»
GlycoMira Therapeuticsโ First-in-Class, Immune-Modulating โฆ
Dr. Tew: GlycoMira Therapeutics is a Salt Lake City-based biopharmaceutical firm founded over a decade ago for technology exclusively licensed from the University of Utah. I joined the โฆSee details»
GlycoMira Press Release 20211026 | GlycoMira.com
Oct 26, 2021 GlycoMira Therapeutics is a privately owned Salt Lake City based biopharmaceutical company focused on the pre-clinical development of innovative anti โฆSee details»
GLYCOMIRA, LLC - VentureRadar
GlycoMira is developing an effective treatment for chronic rhinosinusitis, a debilitating inflammatory disease that substantially diminishes the quality of life and productivity of up to โฆSee details»
GlycoMira Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore GlycoMira Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule โฆSee details»
Award - SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means โฆSee details»
GLYCOMIRA, LLC - VentureRadar
GlycoMira is developing an effective treatment for chronic rhinosinusitis, a debilitating inflammatory disease that substantially diminishes the quality of life and productivity of up to โฆSee details»
GLYCOMIRA, LLC Company Profile | Salt Lake City, UT
Find company research, competitor information, contact details & financial data for GLYCOMIRA, LLC of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»
Award - SBIR
GlycoMira has developed a family of polyanionic, metabolically stabilized polysaccharides, the semi- synthetic glycosaminoglycan ethers (SAGEs). These new drugs have broad anti โฆSee details»
GLYCOMIRA, LLC | SBIR.gov
PROJECT SUMMARYThe goal of this proposal is to optimize and clinically validate a new diagnostic test for eosinophilic chronic rhinosinusitis (eCRS) at the point-of-care, improving the โฆSee details»
Technology | GlycoMira.com
Most therapeutic strategies for oncology target key molecules involved in the late stages of disease progression and are not mechanistically based on the recent understanding of โฆSee details»
GlycoMira - Tech Stack, Apps, Patents & Trademarks - Crunchbase
GlycoMira uses 7 technology products and services including HTML5, Google Fonts, and GoDaddy Premium DNS, according to G2 Stack. GlycoMira is actively using 23 technologies โฆSee details»